Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $177,493 - $227,702
-1,138 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$181.39 - $234.03 $268,275 - $346,130
-1,479 Reduced 56.52%
1,138 $215,000
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $17,044 - $21,738
-88 Reduced 3.25%
2,617 $639,000
Q3 2021

Oct 28, 2021

BUY
$189.29 - $209.69 $57,544 - $63,745
304 Added 12.66%
2,705 $567,000
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $21,358 - $25,754
137 Added 6.05%
2,401 $474,000
Q1 2021

Apr 30, 2021

BUY
$144.0 - $169.39 $7,776 - $9,147
54 Added 2.44%
2,264 $384,000
Q4 2020

Feb 03, 2021

BUY
$157.07 - $174.35 $24,188 - $26,849
154 Added 7.49%
2,210 $366,000
Q3 2020

Nov 16, 2020

BUY
$137.1 - $165.37 $22,073 - $26,624
161 Added 8.5%
2,056 $341,000
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $212,088 - $270,094
1,895 New
1,895 $301,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Intrua Financial, LLC Portfolio

Follow Intrua Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.